SPONSOR
Christine Ryan
Total Trials
2
Recruiting
2
Phases
Phase 2
Conditions studied: Chronic Lymphocytic LeukemiaRichter's TransformationMantle Cell LymphomaLymphoma
NCT06043674 Phase 2
Recruiting
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
Chronic Lymphocytic Leukemia
NCT06854003 Phase 2
Recruiting
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
Mantle Cell Lymphoma